Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome.
Fragile X syndrome (FXS) is a leading cause of inherited mental retardation. In the vast majority of cases, this X-linked disorder is due to a CGG expansion in the 5' untranslated region of the fmr-1 gene and the resulting decreased expression of its associated protein, FMRP. FXS is characterized by a number of cognitive, behavioral, anatomical, and biological abnormalities. FXS provides a unique opportunity to study the consequence of mutation in a single gene on the development and proper functioning of the CNS. The current focus on the role of FMRP in neuronal maturation makes it timely to assemble the extant information on how reduced expression of the fmr-1 gene leads to neuronal dysmorphology. The purpose of this review is to summarize recent genetic, neuroanatomical, and behavioral studies of fragile X syndrome and to offer potential mechanisms to account for the pleiotropic phenotype of this disorder.
Koukoui
Sophia Dona
SD
Department of Psychology, McGill University, 1205 Dr. Penfield Avenue, Montreal, QC H3A 1B1 Canada. sophia.koukoui@mail.mcgill.ca <sophia.koukoui@mail.mcgill.ca>
Chaudhuri
Avi
A
D000818:Animals; D001921:Brain / Q000002:abnormalities / Q000473:pathology / Q000503:physiopathology*; D003599:Cytoskeleton / Q000378:metabolism / Q000473:pathology; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000096:biosynthesis / Q000235:genetics*; D005600:Fragile X Syndrome / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D018507:Gene Expression Regulation, Developmental / Q000235:genetics*; D006801:Humans; D017774:Long-Term Potentiation / Q000235:genetics; D009154:Mutation / Q000235:genetics*; D010641:Phenotype; D018094:Receptors, Metabotropic Glutamate / Q000378:metabolism
D051860:Fragile X Messenger Ribonucleoprotein 1; D018094:Receptors, Metabotropic Glutamate; C497683:FMR1 protein, human; C104077:metabotropic glutamate receptor type 1